MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
ENDRA Life Sciences DIO Ratio 2011-2026 | NDRA
Annual DIO Ratio ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 405 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 405 | 405 | 405 |
Quarterly DIO Ratio ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 148 | 340 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 340 | 148 | 244 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
97.1 | $ 115.19 | 0.1 % | $ 35 B |  USA |
 |
BioNano Genomics
BNGO
|
251 | $ 1.14 | 0.44 % | $ 6.21 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 16.2 | 0.56 % | $ 174 M |  China |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 16.29 | 1.46 % | $ 868 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.41 | 2.92 % | $ 1.88 M | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 23.05 | -0.35 % | $ 640 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 175.38 | -0.17 % | $ 8.69 B | USA |
 |
Danaher Corporation
DHR
|
87.6 | $ 190.7 | 0.6 % | $ 136 B | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 4.47 | 2.64 % | $ 414 M | USA |
 |
Illumina
ILMN
|
137 | $ 122.51 | 1.3 % | $ 19.5 B | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 7.94 | 3.19 % | $ 1.02 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 14.95 | 3.57 % | $ 452 M | USA |
 |
Guardant Health
GH
|
82.1 | $ 78.76 | 0.2 % | $ 9.87 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
147 | $ 2.07 | -3.19 % | $ 4.75 M | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 28.27 | -0.12 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 107.75 | 0.88 % | $ 8.89 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 261.97 | 0.4 % | $ 21.8 B | USA |
 |
Natera
NTRA
|
25.8 | $ 199.83 | 3.52 % | $ 19.7 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 6.67 | -0.15 % | $ 278 M | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 80.99 | 0.5 % | $ 5.47 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 192.07 | 0.29 % | $ 21.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.58 | -0.1 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.19 | -2.46 % | $ 1.99 B | USA |
 |
Organovo Holdings
ONVO
|
371 | - | -2.3 % | $ 19.4 M | USA |